Request for Covid-19 Impact Assessment of this Report

Healthcare

Covid-19 Impact on Bisphosphonate Drug Market , Global Research Reports 2020-2021

  • BMR3851439
  • 93 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.

This report provides a complete quantitative data and qualitative analysis on the global market for Bisphosphonate Drug. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.

Prior to COVID-19, the global market for Bisphosphonate Drug was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Bisphosphonate Drug is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.

This report covers market size and forecasts of Bisphosphonate Drug, including the following market information:

Global Bisphosphonate Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Bisphosphonate Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Bisphosphonate Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)

Global Bisphosphonate Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

Key market players

Major competitors identified in this market include Merck, Teva, Mylan, Apotex Corp, Cobalt Pharmaceuticals, Genentech, Novartis Pharmaceuticals, Sanofi-Aventis, etc.

Based on the Region:

Asia-Pacific (China, Japan, South Korea, India and ASEAN)

North America (US and Canada)

Europe (Germany, France, UK and Italy)

Rest of World (Latin America, Middle East & Africa)

Based on the Type:

Alendronate

Risedronate

Zoledronic acid

Other Bisphosphonate Drug

Based on the Application:

Postmenopausal osteoporosis

Men with osteoporosis

Paget’s disease

Bone loss caused by cancer treatment

Osteoporosis imperfecta in children

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Bisphosphonate Drug Industry

1.7 COVID-19 Impact: Bisphosphonate Drug Market Trends

2 Global Bisphosphonate Drug Quarterly Market Size Analysis

2.1 Bisphosphonate Drug Business Impact Assessment - COVID-19

2.1.1 Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Bisphosphonate Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Bisphosphonate Drug Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Bisphosphonate Drug Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Bisphosphonate Drug Factory Price by Manufacturers

3.3 Location of Key Manufacturers Bisphosphonate Drug Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Bisphosphonate Drug Market

3.5 Key Manufacturers Bisphosphonate Drug Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Bisphosphonate Drug Segments, By Type

4.1 Introduction

1.4.1 Alendronate

1.4.2 Risedronate

1.4.3 Zoledronic acid

1.4.4 Other Bisphosphonate Drug

4.2 By Type, Global Bisphosphonate Drug Market Size, 2019-2021

4.2.1 By Type, Global Bisphosphonate Drug Market Size by Type, 2020-2021

4.2.2 By Type, Global Bisphosphonate Drug Price, 2020-2021

5 Impact of Covid-19 on Bisphosphonate Drug Segments, By Application

5.1 Overview

5.5.1 Postmenopausal osteoporosis

5.5.2 Men with osteoporosis

5.5.3 Paget’s disease

5.5.4 Bone loss caused by cancer treatment

5.5.5 Osteoporosis imperfecta in children

5.2 By Application, Global Bisphosphonate Drug Market Size, 2019-2021

5.2.1 By Application, Global Bisphosphonate Drug Market Size by Application, 2019-2021

5.2.2 By Application, Global Bisphosphonate Drug Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Merck

7.1.1 Merck Business Overview

7.1.2 Merck Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.1.3 Merck Bisphosphonate Drug Product Introduction

7.1.4 Merck Response to COVID-19 and Related Developments

7.2 Teva

7.2.1 Teva Business Overview

7.2.2 Teva Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.2.3 Teva Bisphosphonate Drug Product Introduction

7.2.4 Teva Response to COVID-19 and Related Developments

7.3 Mylan

7.3.1 Mylan Business Overview

7.3.2 Mylan Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.3.3 Mylan Bisphosphonate Drug Product Introduction

7.3.4 Mylan Response to COVID-19 and Related Developments

7.4 Apotex Corp

7.4.1 Apotex Corp Business Overview

7.4.2 Apotex Corp Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.4.3 Apotex Corp Bisphosphonate Drug Product Introduction

7.4.4 Apotex Corp Response to COVID-19 and Related Developments

7.5 Cobalt Pharmaceuticals

7.5.1 Cobalt Pharmaceuticals Business Overview

7.5.2 Cobalt Pharmaceuticals Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Product Introduction

7.5.4 Cobalt Pharmaceuticals Response to COVID-19 and Related Developments

7.6 Genentech

7.6.1 Genentech Business Overview

7.6.2 Genentech Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.6.3 Genentech Bisphosphonate Drug Product Introduction

7.6.4 Genentech Response to COVID-19 and Related Developments

7.7 Novartis Pharmaceuticals

7.7.1 Novartis Pharmaceuticals Business Overview

7.7.2 Novartis Pharmaceuticals Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.7.3 Novartis Pharmaceuticals Bisphosphonate Drug Product Introduction

7.7.4 Novartis Pharmaceuticals Response to COVID-19 and Related Developments

7.8 Sanofi-Aventis

7.8.1 Sanofi-Aventis Business Overview

7.8.2 Sanofi-Aventis Bisphosphonate Drug Quarterly Production and Revenue, 2020

7.8.3 Sanofi-Aventis Bisphosphonate Drug Product Introduction

7.8.4 Sanofi-Aventis Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Bisphosphonate Drug Supply Chain Analysis

8.1.1 Bisphosphonate Drug Supply Chain Analysis

8.1.2 Covid-19 Impact on Bisphosphonate Drug Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Bisphosphonate Drug Distribution Channels

8.2.2 Covid-19 Impact on Bisphosphonate Drug Distribution Channels

8.2.3 Bisphosphonate Drug Distributors

8.3 Bisphosphonate Drug Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Bisphosphonate Drug Assessment

Table 9. COVID-19 Impact: Bisphosphonate Drug Market Trends

Table 10. COVID-19 Impact Global Bisphosphonate Drug Market Size

Table 11. Global Bisphosphonate Drug Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Bisphosphonate Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Bisphosphonate Drug Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Bisphosphonate Drug Market Growth Drivers

Table 17. Global Bisphosphonate Drug Market Restraints

Table 18. Global Bisphosphonate Drug Market Opportunities

Table 19. Global Bisphosphonate Drug Market Challenges

Table 20. Key Manufacturers Bisphosphonate Drug Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Bisphosphonate Drug Market Size, 2019 (K MT) & (US$ Million)

Table 22. Bisphosphonate Drug Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Bisphosphonate Drug Manufacturing Plants

Table 24. Key Manufacturers Bisphosphonate Drug Market Served

Table 25. Date of Key Manufacturers Enter into Bisphosphonate Drug Market

Table 26. Key Manufacturers Bisphosphonate Drug Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Bisphosphonate Drug Market Size by Type, 2020, (US$ Million)

Table 29. Global Bisphosphonate Drug Market Size by Type, 2020 (K MT)

Table 30. Global Bisphosphonate Drug Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Bisphosphonate Drug Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Bisphosphonate Drug Market Size by Application, 2020-2021 (K MT)

Table 33. Global Bisphosphonate Drug Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Bisphosphonate Drug Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Bisphosphonate Drug Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Bisphosphonate Drug Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Bisphosphonate Drug Market Size, 2019-2021 (K MT)

Table 38. US Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Bisphosphonate Drug Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Bisphosphonate Drug Market Size, 2019-2021 (K MT)

Table 43. Germany Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Bisphosphonate Drug Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Bisphosphonate Drug Market Size, 2019-2021 (K MT)

Table 50. China Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Bisphosphonate Drug Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Merck Business Overview

Table 58. Merck Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Merck Bisphosphonate Drug Product

Table 60. Merck Response to COVID-19 and Related Developments

Table 61. Teva Business Overview

Table 62. Teva Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Teva Bisphosphonate Drug Product

Table 64. Teva Response to COVID-19 and Related Developments

Table 65. Mylan Business Overview

Table 66. Mylan Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Mylan Bisphosphonate Drug Product

Table 68. Mylan Response to COVID-19 and Related Developments

Table 69. Apotex Corp Business Overview

Table 70. Apotex Corp Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Apotex Corp Bisphosphonate Drug Product

Table 72. Apotex Corp Response to COVID-19 and Related Developments

Table 73. Cobalt Pharmaceuticals Business Overview

Table 74. Cobalt Pharmaceuticals Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Cobalt Pharmaceuticals Bisphosphonate Drug Product

Table 76. Cobalt Pharmaceuticals Response to COVID-19 and Related Developments

Table 77. Genentech Business Overview

Table 78. Genentech Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Genentech Bisphosphonate Drug Product

Table 80. Genentech Response to COVID-19 and Related Developments

Table 81. Novartis Pharmaceuticals Business Overview

Table 82. Novartis Pharmaceuticals Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Novartis Pharmaceuticals Bisphosphonate Drug Product

Table 84. Novartis Pharmaceuticals Response to COVID-19 and Related Developments

Table 85. Sanofi-Aventis Business Overview

Table 86. Sanofi-Aventis Bisphosphonate Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Sanofi-Aventis Bisphosphonate Drug Product

Table 88. Sanofi-Aventis Response to COVID-19 and Related Developments

Table 89. Bisphosphonate Drug Distributors List

Table 90. Bisphosphonate Drug Customers List

Table 91. Covid-19 Impact on Bisphosphonate Drug Customers

List of Figures

Figure 1. Bisphosphonate Drug Product Picture

Figure 2. Bisphosphonate Drug Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Bisphosphonate Drug Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Bisphosphonate Drug Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Bisphosphonate Drug Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Bisphosphonate Drug Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Bisphosphonate Drug Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Bisphosphonate Drug Market Size Market Share, 2019-2021

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950